Rituximab and omalizumab in severe, refractory insulin allergy. [electronic resource]
Producer: 20090311Description: 1045-7 p. digitalISSN:- 1533-4406
- Anti-Allergic Agents -- therapeutic use
- Antibodies, Anti-Idiotypic
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Diabetes Mellitus, Type 1 -- drug therapy
- Drug Eruptions -- drug therapy
- Drug Therapy, Combination
- Female
- Humans
- Immunoglobulin E -- blood
- Immunologic Factors -- therapeutic use
- Insulin -- adverse effects
- Middle Aged
- Omalizumab
- Rituximab
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.